Canadian Agency for Drugs and Technologies in Health. (2016). Clinical review report Emtricitabine/tenofovir alafenamide fumarate (Descovy). Canadian Agency for Drugs and Technologies in Health.
Cita Chicago Style (17a ed.)Canadian Agency for Drugs and Technologies in Health. Clinical Review Report Emtricitabine/tenofovir Alafenamide Fumarate (Descovy). Ottawa, Ontario: Canadian Agency for Drugs and Technologies in Health, 2016.
Cita MLA (9a ed.)Canadian Agency for Drugs and Technologies in Health. Clinical Review Report Emtricitabine/tenofovir Alafenamide Fumarate (Descovy). Canadian Agency for Drugs and Technologies in Health, 2016.
Precaución: Estas citas no son 100% exactas.